US 11,905,231 B1
Solid forms, salts and polymorphs of anti-fibrotic compounds
Darren James Kelly, Melbourne (AU); Gareth Rhys Lewis, Melbourne (AU); and Lorna Helen Mitchell, Auckland (NZ)
Assigned to Certa Therapeutics Pty Ltd, Melbourne (AU)
Filed by Certa Therapeutics Pty Ltd, Melbourne (AU)
Filed on Jul. 18, 2023, as Appl. No. 18/354,467.
Claims priority of application No. 2023900229 (AU), filed on Jan. 31, 2023.
Int. Cl. C07C 229/66 (2006.01)
CPC C07C 229/66 (2013.01) [C07B 2200/13 (2013.01)] 30 Claims
 
1. A crystalline form of a pharmaceutically acceptable salt of the compound of Formula (I):

OG Complex Work Unit Chemistry
wherein the crystalline form has a water sorption of less than 1.7% at 25° C. and 80% relative humidity as determined by dynamic vapor sorption.